Abstract
Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have